Market Research Logo

Global Peptide Cancer Vaccine Market Research Report 2018

Global Peptide Cancer Vaccine Market Research Report 2018

This report studies the Peptide Cancer Vaccine market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Peptide Cancer Vaccine market by product type and applications/end industries.

The major players in global Peptide Cancer Vaccine market include
TapImmune
BrightPath Biotherapeutics
Ultimovacs
Sellas
Boston Biomedical
Imugene
VAXON Biotech
Generex Biotechnology
ISA Pharmaceuticals
OncoTherapy Science
Immatics

Geographically, this report is segmented into several key Regions, with market size, market share and growth rate of Peptide Cancer Vaccine in these regions, from 2020 to 2030 (forecast), covering
USA
Europe
China
Japan
South America
RoW

On the basis on the end users/applications, this report covers
Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Others


1 Peptide Cancer Vaccine Market Overview
1.1 Peptide Cancer Vaccine Product Overview
1.2 Peptide Vaccine Strategies in the Treatment of Cancer
1.3 Global Peptide Cancer Vaccine Segment by Applications
1.3.1 Global Peptide Cancer Vaccine Revenue Market Share by Applications in 2025
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Melanoma
1.3.5 Prostate Cancer
1.4 Global Peptide Cancer Vaccine Market by Regions (2020-2030)
1.4.1 Global Peptide Cancer Vaccine Market Size and Growth Rate Comparison by Regions (2020-2030)
1.4.2 USA Peptide Cancer Vaccine Status and Prospect (2020-2030)
1.4.3 Europe Peptide Cancer Vaccine Status and Prospect (2020-2030)
1.4.4 Japan Peptide Cancer Vaccine Status and Prospect (2020-2030)
1.4.5 China Peptide Cancer Vaccine Status and Prospect (2020-2030)
1.4.6 South America Peptide Cancer Vaccine Status and Prospect (2020-2030)
1.5 Global Peptide Cancer Vaccine Market Size (2020-2030)
1.6 Global Manufacturers Peptide Cancer Vaccine Headquarters, Established Date and Product
2 Cancer Vaccines and Immunotherapy
2.1 Therapeutic Vaccines
2.1.1 Autologous Cancer Vaccines
2.1.2 Allogenic Cancer Vaccines
2.1.3 Protein or Peptide Cancer Vaccines
2.1.4 DNA Vaccines
2.2 Other Approaches
2.3 Clinical Considerations for Therapeutic Cancer Vaccines
2.3.1 Considerations for both Early and Late Phase Clinical Trials
2.3.2 Considerations for Early Phase Clinical Trials
2.3.3 Considerations for Late Phase Clinical Trials
3 Wide Spectrum Action of Peptide Cancer Vaccines against Major Cancer
3.1 Peptides & Colorectal Cancer
3.1.1 Colorectal Cancer Introduction
3.1.2 Introduction of the Number of Patients with Colorectal Cancer
3.1.3 Peptide Cancer Vaccine Introduction about Colorectal Cancer
3.2 Peptides & Lung Cancer
3.2.1 Lung Cancer Introduction
3.2.2 Introduction of the Number of Patients with Lung Cancer
3.2.3 Peptide Cancer Vaccine Introduction about Lung Cancer
3.3 Peptides & Pancreatic Cancer
3.3.1 Pancreatic Cancer Introduction
3.3.2 Introduction of the Number of Patients with Pancreatic Cancer
3.3.3 Peptide Cancer Vaccine Introduction about Pancreatic Cancer
3.4 Peptides & Breast Cancer
3.4.1 Breast Cancer Introduction
3.4.2 Introduction of the Number of Patients with Breast Cancer
3.4.3 Peptide Cancer Vaccine Introduction about Breast Cancer
3.5 Peptides & Prostate Cancer
3.5.1 Prostate Cancer Introduction
3.5.2 Introduction of the Number of Patients with Prostate Cancer
3.5.3 Peptide Cancer Vaccine Introduction about Prostate Cancer
3.6 Peptides & Other Cancer
4 Global Peptide Cancer Vaccine by Pipeline
4.1 ITK-1
4.2 GRN-1201
4.3 TPIV200
4.4 TPIV110
4.5 UV1
4.6 galinpepimut-S
4.7 TARP 27-35
4.8 HER-Vaxx
4.9 Vx-001
4.10 Vx-006
4.11 Vx-016
4.12 AE37
4.13 ISA101 (HPV)
4.14 MyISA (Personalized immunotherapy based on neoantigens)
4.15 ISA203 (PRAME)
4.16 ISA204 (HBV)
4.17 OTSA101
4.18 GALINPEPIMUT-S AND KEYTRUDA (PEMBROLIZUMAB)
4.19 ACTolog
4.20 DSP-7888 Dosing Emulsion plus Bevacizumab
4.21 DSP-7888 in Patients with Myelodysplastic Syndrome (MDS)
4.22 DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
4.23 DSP-7888 Dosing Emulsion in Adult Patients with Advanced Malignancies
5 Global Cancer Vaccine Consumption by Regions (2013-2018)
5.1 Global Cancer Vaccine Consumption by Regions (2013-2018)
5.2 North America Cancer Vaccine Consumption (2013-2018)
5.3 Europe Cancer Vaccine Consumption (2013-2018)
5.4 China Cancer Vaccine Consumption (2013-2018)
5.5 Japan Cancer Vaccine Consumption (2013-2018)
6 Cancer Vaccine Market Size Analysis by Main Players 2013-2018
6.1 Global Cancer Vaccine Sales and Share by Manufacturers (2013-2018)
6.2 Global Cancer Vaccine Revenue and Share by Manufacturers (2013-2018)
6.3 Vaccine Market Size Analysis by Main Players
6.3.1 Merck
6.3.2 GSK
6.3.3 Dendreon
7 Analysis of Peptide Cancer Vaccine Industry Key Manufacturers
7.1 Boston Biomedical
7.1.1 Company Profile
7.1.2 Product Information
7.2 Ultimovacs
7.2.1 Company Profile
7.2.2 Product Information
7.3 BrightPath Biotherapeutics
7.3.1 Company Profile
7.3.2 Product Information
7.4 TapImmune
7.4.1 Company Profile
7.4.2 Product Information
7.5 Immatics
7.5.1 Company Profile
7.5.2 Product Information
7.6 Sellas
7.6.1 Company Profile
7.6.2 Product Information
7.7 Imugene
7.7.1 Company Profile
7.7.2 Product Information
7.8 VAXON Biotech
7.8.1 Company Profile
7.8.2 Product Information
7.9 Generex Biotechnology
7.9.1 Company Profile
7.9.2 Product Information
7.10 ISA Pharmaceuticals
7.10.1 Company Profile
7.10.2 Product Information
7.11 OncoTherapy Science
7.11.1 Company Profile
7.11.2 Product Information
8 Peptide Cancer Vaccine Manufacturing Cost Analysis
8.1 Peptide Cancer Vaccine R&D Cost Analysis
8.1.1 Clinical Phase Costs
8.1.2 Capitalized Costs
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Other Costs Analysis
8.3 Manufacturing Process Analysis of Peptide Cancer Vaccine
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Peptide Cancer Vaccine Peptide Cancer Vaccine Discovery and Development Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Downstream Buyers
10 Marketing Strategy Analysis
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
11 Market Effect Factors Analysis
11.1 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Peptide Cancer Vaccine Market Forecast (2020-2030)
12.1 Global Peptide Cancer Vaccine Revenue Forecast (2020-2030)
12.2 Global Peptide Cancer Vaccine Revenue Forecast by Regions (2020-2030)
12.3 Global Peptide Cancer Vaccine Consumption Forecast by Regions (2020-2030)
12.3.1 USA Peptide Cancer Vaccine Consumption Forecast (2020-2030)
12.3.2 Europe Peptide Cancer Vaccine Consumption Forecast (2020-2030)
12.3.3 China Peptide Cancer Vaccine Consumption Forecast (2020-2030)
12.3.4 Japan Peptide Cancer Vaccine Consumption Forecast (2020-2030)
12.3.5 South America Peptide Cancer Vaccine Consumption Forecast (2020-2030)
12.4 Global Peptide Cancer Vaccine Consumption Forecast by Application (2020-2030)
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Tables and Figures
Figure Product Picture of Peptide Cancer Vaccine
Figure Global Peptide Cancer Vaccine Revenue Market Share by Applications in 2025
Figure Breast Cancer Examples
Figure Lung Cancer Examples
Figure Melanoma Examples
Figure Prostate Cancer Examples
Table Peptide Cancer Vaccine Market Size (M USD) Comparison by Regions (2020-2030)
Figure USA Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030)
Figure Europe Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030)
Figure Japan Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030)
Figure China Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030)
Figure South America Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030)
Figure Global Peptide Cancer Vaccine Revenue (M USD) Status and Outlook (2020-2030)
Table Global Players/Manufacturers Peptide Cancer Vaccine Headquarters and Established Date
Table Global Manufacturers Peptide Cancer Vaccine Product
Top 20 Countries Highest Incidence of Colorectal Cancer in 2016
Top 20 Countries Highest Incidence of Lung Cancer in 2016
Figure Percent of New Cases by Age Group: Lung Cancer
Figure Percent of Deaths by Age Group: Lung Cancer
Table Active Immunotherapies in Phase III Development
Top 20 Countries Highest Incidence of Pancreatic Cancer in 2016
Table Active Immunotherapies in Phase III Development
Top 20 Countries Highest Incidence of Breast Cancer in 2016
Table Active Immunotherapies in Phase III Development
Figure Percent of New Cases by Age Group: Prostate Cancer
Figure Percent of Deaths by Age Group: Prostate Cancer
Figure Estimated Prostate Cancer Incidence Worldwide in 2016
Information about World Cancer Statistics for the Most Common Cancers (excluding non-melanoma Skin Cancer) in 2016
Table Active Immunotherapies in Phase III Development
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics
Figure UV1 Technology
Figure How HER-Vaxx is Tntended to Work
Figure Molecular Modeling Study-MHC Class II Receptor
Figure Li Suppression
Figure Li-KEY Hybrid
Figure Antitumor Activity of OTSA101
Figure Peptide Cancer Vaccine Product Information of Sellas
Figure Peptide Cancer Vaccine Product Information of Immatics
Figure Peptide Cancer Vaccine Product Information of Boston Biomedical
Figure Peptide Cancer Vaccine Product Information of Sumitomo Dainippon
Figure Peptide Cancer Vaccine Product Information of Sumitomo Dainippon
Figure Peptide Cancer Vaccine Product Information of Boston Biomedical
Table Global Cancer Vaccine Consumption (K Doses) Market by Regions (2013-2018)
Table Global Cancer Vaccine Consumption Market Share by Regions (2013-2018)
Figure Global Cancer Vaccine Consumption Market Share by Regions (2013-2018)
Figure 2017 Global Cancer Vaccine Consumption Market Share by Regions
Table Global Cancer Vaccine Revenue (M USD) Market by Regions (2013-2018)
Table Global Cancer Vaccine Revenue Market Share by Regions (2013-2018)
Figure Global Cancer Vaccine Revenue Market Share by Regions (2013-2018)
Figure 2017 Global Cancer Vaccine Revenue Market Share by Regions
Figure North America Cancer Vaccine Consumption (K Doses) and Growth Rate (2013-2018)
Figure North America Cancer Vaccine Revenue (M USD) and Growth Rate (2013-2018)
Figure Europe Cancer Vaccine Consumption (K Doses) and Growth Rate (2013-2018)
Figure Europe Cancer Vaccine Revenue (M USD) and Growth Rate (2013-2018)
Figure China Cancer Vaccine Consumption (K Doses) and Growth Rate (2013-2018)
Figure China Cancer Vaccine Revenue (M USD) and Growth Rate (2013-2018)
Figure Japan Cancer Vaccine Consumption (K Doses) and Growth Rate (2013-2018)
Figure Japan Cancer Vaccine Revenue (M USD) and Growth Rate (2013-2018)
Table Global Cancer Vaccine Sales (K Doses) of Key Manufacturers (2013-2018)
Table Global Cancer Vaccine Sales Market Share by Manufacturers (2013-2018)
Figure 2013 Cancer Vaccine Sales Market Share by Manufacturers
Figure 2017 Cancer Vaccine Sales Market Share by Manufacturers
Table Global Cancer Vaccine Revenue (M USD) by Manufacturers (2013-2018)
Table Global Cancer Vaccine Revenue Share by Manufacturers (2013-2018)
Figure 2013 Global Cancer Vaccine Revenue Share by Manufacturers
Figure 2017 Global Cancer Vaccine Revenue Share by Manufacturers
Table Merck Company Profile
Table Cancer Vaccine Product Information of Merck
Table Cancer Vaccine Sales (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2013-2018
Figure Cancer Vaccine Sales (K Doses) and Growth Rate of Merck 2013-2018
Figure Cancer Vaccine Revenue (M USD) and Global Market Share of Merck 2013-2018
Table GSK Company Profile
Table Cancer Vaccine Product Information of GSK
Table Cancer Vaccine Sales (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GSK 2013-2018
Figure Cancer Vaccine Sales (K Doses) and Growth Rate of GSK 2013-2018
Figure Cancer Vaccine Revenue (M USD) and Global Market Share of GSK 2013-2018
Table Dendreon Company Profile
Table Cancer Vaccine Product Information of Dendreon
Table Cancer Vaccine Sales (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dendreon 2013-2018
Figure Cancer Vaccine Sales (K Doses) and Growth Rate of Dendreon 2013-2018
Figure Cancer Vaccine Revenue (M USD) and Global Market Share of Dendreon 2013-2018
Table Boston Biomedical Company Profile
Figure Peptide Cancer Vaccine Product Information of Boston Biomedical
Table Ultimovacs Company Profile
Table Peptide Cancer Vaccine Product Picture and Specifications of Ultimovacs
Table BrightPath Biotherapeutics Company Profile
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics
Table TapImmune Company Profile
Figure Peptide Cancer Vaccine Product Picture and Specifications of TapImmune
Table Immatics Company Profile
Figure Peptide Cancer Vaccine Product Information of Immatics
Table Sellas Company Profile
Figure Peptide Cancer Vaccine Product Information of Sellas
Table Imugene Company Profile
Figure Peptide Cancer Vaccine Product Picture of Imugene
Table VAXON Biotech Company Profile
Figure Peptide Cancer Vaccine Product Picture of VAXON Biotech
Table Generex Biotechnology Company Profile
Figure Peptide Cancer Vaccine Product Picture of Generex Biotechnology
Table ISA Pharmaceuticals Company Profile
Table OncoTherapy Science Company Profile
Figure Peptide Cancer Vaccine Product Picture of OncoTherapy Science
Figure Typical Phases from Research to the Market for a Cancer Vaccine Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Peptide Cancer Vaccine
Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour)
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)
Figure Cost of Employing a Factory Worker
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year)
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month)
Table Average Price of Electricity to Ultimate Customers
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Anti-cancer Process
Figure Manufacturing Process Analysis of Peptide Cancer Vaccine
Figure Roadmap to the Development of Predictive Biomarkers for Active Immunotherapy
Figure Peptide Cancer Vaccine Discovery and Development
Table Major Buyers of Peptide Cancer Vaccine
Figure Setting Pricing Policy
Figure Global GDP Growth Rate for 2016
Figure Real GDP Growth 2016-2020 annual Average
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2016-2017
Figure EU GDP 2006-2016 (Billion USD)
Figure EU CPI Change 2012-2016
Figure Germany GDP 2006-2016 (Billion USD)
Figure Germany CPI Change 2016-2017
Figure UK GDP 2006-2016 (Billion USD)
Figure UK CPI Change 2016-2017
Figure Italy GDP 2006-2016 (Billion USD)
Figure Italy CPI Change 2016-2017
Figure Japan GDP 2006-2016 (Billion USD)
Figure Japan CPI Change 2012-2016
Figure China GDP 2006-2016 (Billion USD)
Figure China CPI Change 2016-2017
Figure Global Peptide Cancer Vaccine Revenue (M USD) and Growth Rate Forecast (2020-2030)
Table Global Peptide Cancer Vaccine Revenue (M USD) Forecast by Regions (2020-2025)
Table Global Peptide Cancer Vaccine Revenue (M USD) Forecast by Regions (2025-2030)
Table Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions (2020-2025)
Table Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions (2025-2030)
Figure Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions (2020-2030)
Figure Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions in 2025
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Regions (2020-2025)
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Regions (2025-2030)
Table Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions (2020-2025)
Table Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions (2025-2030)
Figure Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions (2020-2030)
Figure Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions in 2025
Figure USA Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030)
Figure Europe Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030)
Figure China Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030)
Figure Japan Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030)
Figure South America Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030)
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Application (2020-2025)
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Application (2025-2030)
Table Global Peptide Cancer Vaccine Consumption Forecast by Application (2020-2025)
Table Global Peptide Cancer Vaccine Consumption Forecast by Application (2025-2030)
Figure Global Peptide Cancer Vaccine Consumption Forecast by Application (2020-2030)
Figure Global Peptide Cancer Vaccine Consumption Forecast by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report